CounterPath OverviewCounterPath Research & Development
Research & Development expenses for CPAH.
Quarterly R&D Expenses
$1.06M
As of Oct 31, 2020
Annual R&D Expenses (TTM)
$4.84M
↓ 13.67% YoY
Trailing 12 months ending Oct 31, 2020
CounterPath OverviewResearch & Development expenses for CPAH.
As of Oct 31, 2020
Trailing 12 months ending Oct 31, 2020